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Neither intravenous nor intracoronary routes provide targeted
stem cell delivery to recently infarcted myocardium in sufficient
quantities. Direct routes appear preferable. However, most
prior studies have used epicardial injections, which are not practical for routine clinical use. The objective of this study was to
compare cell retention and clearance kinetics between a subepicardial and a subendocardial technique. Methods: We
evaluated 7 dogs with each technique, using 111In-tropolone–
labeled endothelial progenitor cells and serial SPECT/CT for 15
d after injection. Results: In vivo indium imaging demonstrated
comparable degrees of retention: 57% 6 15% for the subepicardial injections and 54% 6 26% for the subendocardial injections.
Clearance half-lives were also similar at 69 6 26 and 60 6 21 h,
respectively. Conclusion: This study demonstrates that subendocardial injections, clinically more practical, show clearance
kinetics comparable to those of subepicardial injections and
will facilitate the ultimate clinical use of this treatment modality.
Key Words: myocardial infarction; stem cell therapy; cell labeling; single photon emission computed tomography
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S

everal articles attest to marked reduction in fibrotic
injury after myocardial infarction after stem cell transplantation in rodent models (1,2). Hence, it was hoped that
this technique could be applied clinically to improve
prognosis. Subsequently, several clinical trials were undertaken with, at best, modest improvement of global or
regional left ventricular function and reduction in the extent
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of myocardial necrosis (3–6). Although many of these trials
were undertaken with an intracoronary injection of cells,
an effective means of targeted delivery to the infarct site
had not been established. In fact, many of the issues that
may play a major role in determining the benefit of cell
transplantation—such as the route of cell delivery (intracoronary, direct epicardial, or endocardial), timing of
injection after myocardial infarction, and preferable tissue
milieu (reperfusion or sustained occlusion)—remain unanswered. Further, a clear association has not been made
between the number of cells engrafted, their residence time
within myocardium, and the degree of myocardial repair.
Because of the small size of an infarct in rodent models, as
compared with that of clinical infarcts, many of these issues
can likely be addressed only in large-animal models.
Cell tracking may be able to provide answers to some of
these questions, at least in terms of establishing the degree
of initial cell delivery, viability, and retention at the transplant site. We have shown that radionuclide labeling can be
performed, using appropriate doses of radioactivity, without
affecting the biologic activity of the cells and still providing
sufficient radioactive signal for imaging in a canine model
of myocardial infarction (7). Experiments performed in our
laboratory indicate that 111In released by either viable or
nonviable stromal cells is not significantly taken up by
these cells, or a rat embryonic cardiomyoblast H9c2 cell
line, and is rapidly cleared from the site of injection (8).
Most radioactive signal observed after transplantation remains within viable cells, and from our work we see little
evidence that the radioactivity persists in macrophages at
the injection site.
We have established a canine model of myocardial infarction that can be used, with SPECT, to track the fate of
111In-tropolone–labeled autologous cells after transplantation
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by an epicardial injection (9). Epicardial injections, which
would require at the least a minithoracotomy if they were to
be applied clinically, are likely not practical for patients
with a recent myocardial infarction. Rather, direct endocardial injections via a left ventricular catheter may provide
an alternative, but the degree of cell retention would need
to be demonstrated as comparable to epicardial injections
performed under direct vision. Recently, the literature has
suggested that endothelial progenitor cells may be more
effective than other marrow or peripheral blood cell lines
in promoting cardiac repair after myocardial infarction
(10–12). We have chosen to use this cell line for these
experiments.
The present study was undertaken to address the following specific issue: are endocardial injections comparable to
direct epicardial injections in terms of the fraction of cells
initially transplanted and their retention over the first 2 wk?

ventricular catheter. Four endocardial injections were on the day
of the infarction and 3 at 1 wk (Fig. 1).
Cell Preparation
Thirty milliliters of peripheral blood were harvested from each
animal 8 wk before the cell injection. Endothelial progenitor cells
were isolated and identified as described by He et al. (14) (Fig. 2).
Cell cultures were expanded to approximately 30 · 106 cells and
labeled with 111In-tropolone (7). Cell viability experiments were
conducted to ensure the dose of radiation used did not show any
effect on viability or proliferation.
Cell Transplantation
Endocardial Injections. A 7-French introducer sheath was
inserted into the femoral artery, the animals were given 2,000

MATERIALS AND METHODS
Animal Preparation
Fourteen 20- to 24-kg adult female bred-for-research hounds
were used. All procedures were approved by the Animal Care
Committee of the University of Western Ontario and performed
according to the Guide to the Care and Use of Experimental
Animals, Canadian Council on Animal Care and Use of Laboratory Animals, National Research Council (13). We used a 2-h left
anterior descending coronary artery occlusion and reperfusion
model. Seven animals received cells administered under direct
vision by an open thoracotomy on the day of infarction. The other
7 received cells administered into the subendocardium using a left

FIGURE 1. Endothelial progenitor cells labeled with 111In
were injected by subepicardial injection (n 5 7) on day of
infarction (A), subendocardial injection on day of infarction
(n 5 4) (B), or subendocardial injection at 1 wk after
infarction (n 5 3) (C). Follow-up imaging with SPECT/CT
occurred 4, 10, and 15 d after cell transplantation.
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FIGURE 2. Endothelial progenitor cells expressing positive
uptake of fluorescence-labeled acetylated low-density lipoprotein (red color; DiI-acetylated low-density lipoprotein;
Biomedical Technologies Inc.) and Hoechst (blue color) stain
(confocal scanning microscopy; ·200) (A); immunostaining
using antibodies against vascular endothelial growth factor
receptor 2 (red color; Santa Cruz Biotechnology) and
Hoechst (blue color) stain (confocal scanning microscopy;
·400) (B); and immunostaining using antibodies against von
Willebrand factor (red color; Dako Corp.) and Hoechst (blue
color) stain (confocal scanning microscopy; ·400) (C).
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units of heparin intravenously, and catheters were flushed with
heparinized saline (10 U/mL). In the angiography suite, with the
animal supine, biplane right anterior (30) and left anterior
oblique (60) contrast ventriculograms (Omnipaque; GE Healthcare) were obtained using a 6-French pigtail catheter. Outlines
mapping the left ventricle end-diastolic endocardial contour were
drawn by hand on transparencies using the ventriculograms. These
contours were used to map each targeted subendocardial injection.
Endocardial injections were performed using the Stiletto Endomyocardial Injection System (Boston Scientific) under radiographic fluoroscopic guidance. This system uses a retractable
26-gauge needle, which extends beyond its casing with a length of
3.5 mm. The Stilletto catheter was guided to the endocardium
inside a 7-French guiding catheter, which has a radiopaque marker,
allowing visualization of when the catheter is perpendicular to
the endocardial wall. With confirmation of endocardial contact, the
Stilletto catheter was advanced to the edge of the guiding catheter
and the triggering button depressed to propel the spring-loaded
needle into the myocardium for cell injection. Multiple (8–10)
injections within 1–2 cm into the periinfarct region were performed
for each animal.
Epicardial Injections
Cells were injected directly into the periinfarct region (by visual
assessment of both discoloration and regional wall motion at the
epicardial surface) at multiple sites (8–10) using a 25-gauge needle.
Nuclear Medicine Imaging and Analysis
Whole-Body Imaging. Canines were transported to the SPECT/
CT (Symbia T6; Siemens) suite, 30–40 min after injection. A
whole-body scan was acquired, and the counts for the whole body
and region over the heart were calculated and backgroundcorrected; counts have been presented as the heart–to–whole body
ratio expressed as percentages (Table 1).
SPECT/Contrast-Enhanced CT
The SPECT portion consisted of 64 projections (30 s/
projection, 128 · 128 image matrix) and unenhanced CT
(130kVp, 15mAs) at end expiration. Fifty 2.5-mm axial image
slices were obtained across the heart. Subsequently, a 30-mL bolus
of CT contrast (300 mg of iodine/mL; Omnipaque) was injected
intravenously and cardiac gated helical CT (130 kVp, 35 mAs)
was immediately performed using a calcium scoring protocol (15).
Follow-up scans were performed at 4, 10, and up to 15 d after
injection. As the 111In decayed over time, image acquisition time
increased to improve image quality (Fig. 3).
After background correction, the 111In projection data were
reconstructed with ordered-subset expectation maximization (3
iterations, 16 subsets) incorporating resolution compensation and
filtered with a gaussian filter of 5.4 mm in full width at half
maximum. The reconstructed image array was 128 · 128 · 128
(2.7-mm isotropic voxel size). A volume of interest was defined on
day 0 images by pixels at least 30% of the maximum pixel
intensity. The mean pixel intensity was fit to a monoexponential
function in MATLAB (MathWorks) (Fig. 3), and the half-life in
hours was reported (Table 1).
Statistics
Data are expressed as mean 6 SD. Comparison of the degree of
engraftment between the 2 techniques was performed using
a univariate ANOVA in SPSS (SPSS Inc.). Statistical significance
was set at a P value less than 0.05.

RESULTS

Cells were labeled with 0.11 6 0.02 Bq/cell of 111
In. Seven animals received 28 · 106 6 3 · 106 cells by
epicardial injection, and 7 animals received 28 · 106 6 5 ·
106 cells by endocardial injection. The cardiac SPECT/CT
showed areas of hypoperfusion in all animals. The initial
cell retention was comparable for the subepicardial (57% 6
15%) and subendocardial (54% 6 26%) injections (P 5
0.53). The clearance half-lives (Fig. 3A) were also similar
at 69 6 26 and 60 6 21 h, respectively (P 5 0.81).
Representative images are shown in Figure 4. When the
endocardial injections were compared, the half-life of cell
clearance at day 0 (74.6 6 15.3 h) was longer than at week
1 (41.3 6 0.8 h) (P 5 0.015, power 5 0.83).
DISCUSSION

Although intravenous or intracoronary injections of cells
seems attractive because of its relative ease, the actual
number of cells delivered to the infarct site is minimal in
animal studies (16). Direct intramyocardial injections appear
more favorable (17), but subendocardial injections would
be easier to apply clinically. The forces that influence cell
TABLE 1. Biologic Half-Lives and Initial Cell Retention
from Endothelial Progenitor Cell Injections

Group
Epicardial
injection, day 0
Dog 1
Dog 2
Dog 3
Dog 4
Dog 5
Dog 6
Dog 7
Mean 6 SD
Endocardial
injection, day 0
Dog 8
Dog 9
Dog 10
Dog 11
Mean 6 SD
Endocardial
injection, week 1
Dog 12
Dog 13
Dog 14
Mean 6 SD
Total endocardial
mean 6 SD

Heart–to–whole
body ratio, on
injection day

Long half-life (h)

58%
*
51%
56%
69%
32%
74%
57% 6 15%

48.44
59.70
50.89
84.39
40.56
82.62
113.31
68.6 6 25.9

78%
72%
82%
60%
73% 6 10%y

55.99
68.60
83.62
90.16
74.6 6 15.3z

44%
20%
19%
28% 6 14%y
54% 6 26%

42.11
40.49
41.46
41.3 6 0.8z
60.4 6 20.8

*Whole-body SPECT image not acquired.
P 5 0.004 between cell retention (heart–to–whole body ratio)
for endocardial injection at day 0 vs. week 1.
z
P 5 0.015 between half-life of cell clearance of endocardial
injection at day 0 vs. week 1.
y
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FIGURE 4. Day 0 imaging showing transaxial plane in 2
canine hearts. (A and B) Contrast-enhanced CT images, with
arrow denoting hypoenhanced region within infarction. (C
and D) Contrast-enhanced images fused with SPECT
images of transplanted endothelial progenitor cells labeled
with 111In. Images of first dog (A and C) show cells
transplanted by epicardial injection, and images of second
dog (B and D) show cells transplanted by endocardial
injection in relation to region of infarction.

FIGURE 3. (A) SPECT in vivo time–activity curves of 111In
activity, decay-corrected and fit to monoexponential function, for epicardial and endocardial endothelial progenitor
cell injections, from which half-life of cell clearance was
calculated. Epicardial injections had clearance half-life of
69 6 26 h, and endocardial injections had clearance half-life
of 60 6 21 h. Symbols represent normalized raw data.
Representative images are shown (B–E) of SPECT scans
acquired with increasing acquisition time. Day 0 (30 s/
projection) (B), day 4 (30 s/projection) (C), day10 (120 s/
projection) (D), and day 15 (180 s/projection) (E).

loss with an endocardial injection would, in theory, be
different from those affecting an epicardial injection with
the cyclic beat-to-beat changes in intramyocardial pressures
perhaps producing different effects in the subendocardium
versus subendocardium.
Transmural gradients in systolic and diastolic pressure
have been reported, demonstrating higher pressures within
the subendocardium during systole and lower pressures
during diastole relative to the subepicardium and potentially producing transmural differences in contractility
(18,19). Subendocardial pressure was greater than intra-
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cavitary pressure, whereas subepicardial pressure was not
(18). These findings suggest several important differences
that may affect clearance kinetics of injected material.
Grossman et al. demonstrated that retention of neutronactivated microspheres (diameter, 15 mm) in a porcine
model was greater after endocardial injection, using our
same Stiletto Endomyocardial Injection System, than after
epicardial injection. Further optimization of transendocardial delivery suggests that parameters such as needle length
and injection volume can improve retention of various
injectable materials (20).
We found no significant overall difference between the
endocardial and epicardial injection methods in either the
initial cell retention or the clearance kinetics, indicating
that the injection strategies were comparable. However,
although the number of animals is limited, the clearance
half-life of cells injected via the subendocardial route at
1 wk was statistically significantly less than when cells
were injected by the same route on the day of infarction.
Theoretically, when cells die, they may be taken up by macrophages, which invade the infarct area. The time course of
macrophage invasion into the canine infarct has been described previously and shown to peak at 1 wk after injury
(21). If transplanted cells had died and either free indium
that was released from cells or radioactive cell debris was
taken up by these macrophages, then one would have expected the apparent cell clearance time to have been prolonged at 1 wk rather than shorter as appears to be the case.
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The efficacy of treatment was not evaluated in these
experiments. This study was designed purely to assess the
degree of cell retention followed by clearance kinetics. The
use of the endocardial approach has been validated as an
effective means of cell delivery and can be used in future
experiments to assess the optimum timing of injection, as
the same animal could potentially receive multiple labeled
injections at different times to evaluate clearance kinetics
and retention strategies.
CONCLUSION

The transplanted cell retention and cell clearance kinetics
of catheter-based endocardial injections are equivalent to
those of direct epicardial injections.
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